Neil R. Hartman

2.2k total citations
41 papers, 1.9k citations indexed

About

Neil R. Hartman is a scholar working on Molecular Biology, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Neil R. Hartman has authored 41 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Infectious Diseases and 11 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Neil R. Hartman's work include HIV/AIDS drug development and treatment (14 papers), Biochemical and Molecular Research (10 papers) and HIV Research and Treatment (8 papers). Neil R. Hartman is often cited by papers focused on HIV/AIDS drug development and treatment (14 papers), Biochemical and Molecular Research (10 papers) and HIV Research and Treatment (8 papers). Neil R. Hartman collaborates with scholars based in United States, Ukraine and Italy. Neil R. Hartman's co-authors include David G. Johns, Robert Yarchoan, Carlo Federico Perno, Hiroaki Mitsuya, David A. Cooney, Hao Zhang, Samuel Broder, Rose V. Thomas, James M. Pluda and S Broder and has published in prestigious journals such as Science, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Neil R. Hartman

41 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Neil R. Hartman United States	19	1.1k	917	503	454	186	41	1.9k
Andrew Mulato United States	22	1.6k 1.5×	1.2k 1.3×	315 0.6×	586 1.3×	105 0.6×	33	2.1k
Gabriel Birkuš United States	23	1.2k 1.1×	626 0.7×	572 1.1×	577 1.3×	87 0.5×	41	1.9k
Steven S. Good United States	21	952 0.9×	466 0.5×	739 1.5×	1.0k 2.3×	178 1.0×	43	2.5k
Christian Callebaut United States	29	1.7k 1.6×	1.5k 1.6×	544 1.1×	525 1.2×	316 1.7×	96	2.8k
Rob Webster United Kingdom	17	527 0.5×	657 0.7×	705 1.4×	200 0.4×	270 1.5×	26	2.1k
Janet L. Rideout United States	16	1.2k 1.1×	747 0.8×	1.1k 2.3×	726 1.6×	223 1.2×	33	2.5k
R W Klecker United States	11	634 0.6×	478 0.5×	435 0.9×	273 0.6×	128 0.7×	14	1.4k
Mika Okamoto Japan	21	661 0.6×	801 0.9×	642 1.3×	193 0.4×	573 3.1×	65	2.0k
Michael J. M. Hitchcock United States	28	1.7k 1.5×	961 1.0×	956 1.9×	1.2k 2.6×	99 0.5×	78	3.2k
J P Sommadossi United States	21	1.1k 1.0×	621 0.7×	774 1.5×	666 1.5×	47 0.3×	49	2.0k

Countries citing papers authored by Neil R. Hartman

Since Specialization

Citations

This map shows the geographic impact of Neil R. Hartman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil R. Hartman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil R. Hartman more than expected).

Fields of papers citing papers by Neil R. Hartman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil R. Hartman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil R. Hartman. The network helps show where Neil R. Hartman may publish in the future.

Co-authorship network of co-authors of Neil R. Hartman

This figure shows the co-authorship network connecting the top 25 collaborators of Neil R. Hartman. A scholar is included among the top collaborators of Neil R. Hartman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil R. Hartman. Neil R. Hartman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qosa, Hisham, Alexandre J. S. Ribeiro, Neil R. Hartman, & Donna A. Volpe. (2021). Characterization of a commercially available line of iPSC hepatocytes as models of hepatocyte function and toxicity for regulatory purposes. Journal of Pharmacological and Toxicological Methods. 110. 107083–107083. 14 indexed citations

Zere, Tesfalem, Neil R. Hartman, Adarsh Gandhi, et al.. (2019). Effect of drug combinations on the kinetics of antibiotic resistance emergence in Escherichia coli CFT073 using an in vitro hollow-fibre infection model. International Journal of Antimicrobial Agents. 55(4). 105861–105861. 6 indexed citations

Qosa, Hisham, et al.. (2018). In vitro UGT1A1 inhibition by tyrosine kinase inhibitors and association with drug-induced hyperbilirubinemia. Cancer Chemotherapy and Pharmacology. 82(5). 795–802. 38 indexed citations

Hartman, Neil R., et al.. (2002). Production of intracellular 35S-glutathione by rat and human hepatocytes for the quantification of xenobiotic reactive intermediates. Chemico-Biological Interactions. 142(1-2). 43–55. 13 indexed citations

O’Reilly, Séamus, et al.. (2001). Bioavailablility of penclomedine and systemic exposure to 4- O -demethylpenclomedine in patients receiving oral and intravenous penclomedine. Cancer Chemotherapy and Pharmacology. 48(3). 223–228. 2 indexed citations

Hartman, Neil R., et al.. (1998). The in vitro metabolism of penclomedine in mouse, rat, and human systems.. PubMed. 26(6). 513–9. 1 indexed citations

O’Reilly, Séamus, L B Grochow, Ross C. Donehower, et al.. (1997). Phase I and pharmacologic study of penclomedine, a novel alkylating agent, in patients with solid tumors.. Journal of Clinical Oncology. 15(5). 1974–1984. 9 indexed citations

Ford, Harry, et al.. (1997). Reversed-phase high-performance liquid chromatographic determination of the new antitumor agent cyclopentenyl cytosine in biological fluids. Journal of Chromatography B Biomedical Sciences and Applications. 692(1). 169–179. 1 indexed citations

Ahluwalia, Gurpreet S., David A. Cooney, Neil R. Hartman, et al.. (1993). Anomalous accumulation and decay of 2',3'-dideoxyadenosine-5'-triphosphate in human T-cell cultures exposed to the anti-HIV drug 2',3'-dideoxyinosine.. Drug Metabolism and Disposition. 21(2). 369–376. 33 indexed citations

10.

Fried, Michael, Adrian M. Di Bisceglie, Yoon Park, et al.. (1992). A Pilot Study of 2′,3′–Dideoxyinosine for the Treatment of Chronic Hepatitis B. Hepatology. 16(4). 861–864. 32 indexed citations

11.

Zaharko, Daniel S., et al.. (1991). Cyclopentenyl cytosine: Interspecies predictions based on rodent plasma and urine kinetics. Investigational New Drugs. 9(1). 9–17. 9 indexed citations

12.

Hartman, Neil R., Gurpreet S. Ahluwalia, David A. Cooney, et al.. (1991). Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.. Molecular Pharmacology. 40(1). 118–124. 44 indexed citations

13.

Hartman, Neil R., Robert Yarchoan, James M. Pluda, et al.. (1991). Pharmacokinetics of 2',3' -dideoxyinosine in patients with severe human immunodeficiency infection. II. The effects of different oral formulations and the presence of other medications. Clinical Pharmacology & Therapeutics. 50(3). 278–285. 45 indexed citations

14.

Ahluwalia, Gurpreet S., Neil R. Hartman, David A. Cooney, et al.. (1991). Modulation of the antiretroviral activity and anabolism of purine-2′,3′dideoxynucleoside analogs by inhibitors of IMP dehydrogenase. Antiviral Research. 15. 79–79. 1 indexed citations

15.

Hartman, Neil R., David G. Johns, & Hiroaki Mitsuya. (1990). Pharmacokinetic Analysis of Dextran Sulfate in Rats as Pertains to Its Clinical Usefulness for Therapy of HIV Infection. AIDS Research and Human Retroviruses. 6(6). 805–812. 63 indexed citations

16.

Hartman, Neil R., David G. Johns, & Hiroaki Mitsuya. (1990). Pharmacokinetic Study of Dextran Sulfate in Rats. Annals of the New York Academy of Sciences. 616(1). 523–525. 1 indexed citations

17.

Perno, Carlo Federico, Robert Yarchoan, David A. Cooney, et al.. (1989). Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine.. The Journal of Experimental Medicine. 169(3). 933–951. 253 indexed citations

18.

Yarchoan, Robert, Hiroaki Mitsuya, Rose V. Thomas, et al.. (1989). In Vivo Activity Against HIV and Favorable Toxicity Profile of 2′,3′-Dideoxyinosine. Science. 245(4916). 412–415. 369 indexed citations

19.

Perno, Carlo Federico, Robert Yarchoan, David A. Cooney, et al.. (1988). Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.. The Journal of Experimental Medicine. 168(3). 1111–1125. 198 indexed citations

20.

Hartman, Neil R. & Ian Jardine. (1987). The in vitro activity, radioimmunoassay cross-reactivity, and molecular weight of thirteen rabbit cyclosporine metabolites.. Drug Metabolism and Disposition. 15(5). 661–664. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact